Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator- activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR- γ/NF-κB) signaling pathway in endothelial cells

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 9, 2011, Pages 5100-5108

  Kuo, Mei Ying ^a   Ou, Hsiu Chung ^a   Lee, Wen Jane ^b,c   Kuo, Wei Wen ^a   Hwang, Ling Ling ^d   Song, Tuzz Ying ^e   Huang, Chih Yang ^a,f   Chiu, Tsan Hung ^g   Tsai, Kun Ling ^a   Tsai, Chiou Sheng ^b   Sheu, Wayne Huey Herng ^b,h,i,j  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG CHOU INSTITUTE OF TECHNOLOGY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

ⁱ NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^j NATIONAL YANG MING UNIVERSITY   (Taiwan)

more..

Author keywords

Atherosclerotic plaques; Ellagic acid; Matrix metalloproteinases

Indexed keywords

ACUTE MYOCARDIAL INFARCTION; ANTI-ATHEROGENIC EFFECTS; ANTI-INFLAMMATORIES; ATHEROSCLEROTIC PLAQUE; ELLAGIC ACID; EVENT-TRIGGERING; EXTRACELLULAR SIGNAL-REGULATED KINASE; EXTRACELLULAR SIGNALS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; MATRIX METALLOPROTEINASES; METALLOPROTEINASES; MOLECULAR MECHANISM; NUCLEAR FACTORS; OXIDIZED LOW-DENSITY LIPOPROTEINS (OXLDL); PHARMACOLOGICAL INHIBITORS; PHENOLIC COMPOUNDS; POTENT ANTIOXIDANTS; PRE-TREATMENT; PROLIFERATOR; PROTECTIVE EFFECTS; PROTEIN KINASE C; SIGNALING PATHWAYS; VASCULAR ENDOTHELIUM;

BLOOD VESSELS; ENDOTHELIAL CELLS; ENZYME ACTIVITY; ENZYMES; PHENOLS; PHOSPHORYLATION;

SIGNALING;

ELLAGIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C ALPHA;

ARTICLE; CELL CULTURE; DOWN REGULATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

CELLS, CULTURED; DOWN-REGULATION; ELLAGIC ACID; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LIPOPROTEINS, LDL; METALLOPROTEASES; NF-KAPPA B; PPAR GAMMA; PROTEIN KINASE C-ALPHA; SIGNAL TRANSDUCTION;

EID: 79955682150     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf1041867     Document Type: Article

References (36)

1. Libby, P. Molecular bases of the acute coronary syndromes. Circulation 1995, 91 (11), 2844-2850.
2. Henney, A. M.; Wakeley, P. R.; Davies, M. J.; Foster, K.; Hembry, R.; Murphy, G.; Humphries, S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. U.S.A. 1991, 88 (18), 8154-8158. (Pubitemid 21915315)
3. Shin, Y.; Yoon, S. H.; Choe, E. Y.; Cho, S. H.; Woo, C. H.; Rho, J. Y.; Kim, J. H. PMA-induced up-regulation of MMP-9 is regulated by a PKCR-NF-κB cascade in human lung epithelial cells. Exp. Mol. Med. 2007, 39 (1), 97-105. (Pubitemid 46356010)
4. Wang, H. H.; Hsieh, H. L.; Wu, C. Y.; Yang, C. M. Oxidized lowdensity lipoprotein-induced matrix metalloproteinase-9 expression via PKC-δ/p42/p44 MAPK/Elk-1 cascade in brain astrocytes. Neurotox. Res. 2010, 17 (1), 50-65.
5. Marx, N.; Schonbeck, U.; Lazar, M. A.; Libby, P.; Plutzky, J. Peroxisome proliferator-activated receptor γ activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res. 1998, 83 (11), 1097-1103. (Pubitemid 28533518)
6. Liu, J.; Lu, H.; Huang, R.; Lin, D.; Wu, X.; Lin, Q.; Zheng, J.; Pan, X.; Peng, J.; Song, Y.; Zhang, M.; Hou, M.; Chen, F. Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemother. Pharmacol. 2005, 56 (4), 400-408. (Pubitemid 41095403)
7. Francois, M.; Richette, P.; Tsagris, L.; Raymondjean, M.; Fulchignoni-Lataud, M. C.; Forest, C.; Savouret, J. F.; Corvol, M. T. Peroxisome proliferator-activated receptor-γ down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element. J. Biol. Chem. 2004, 279 (27), 28411-28418. (Pubitemid 38900121)
8. Hu, E.; Kim, J. B.; Sarraf, P.; Spiegelman, B. M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 1996, 274 (5295), 2100-2103. (Pubitemid 27020707)
9. Priyadarsini, K. I.; Khopde, S. M.; Kumar, S. S.; Mohan, H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J. Agric. Food Chem. 2002, 50 (7), 2200-2206. (Pubitemid 34260032)
10. Yu, Y. M.; Chang, W. C.; Wu, C. H.; Chiang, S. Y. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J. Nutr. Biochem. 2005, 16 (11), 675-681.
11. Chang, W. C.; Yu, Y. M.; Chiang, S. Y.; Tseng, C. Y. Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. Br. J. Nutr. 2008, 99 (4), 709-714.
12. Papoutsi, Z.; Kassi, E.; Chinou, I.; Halabalaki, M.; Skaltsounis, L. A.; Moutsatsou, P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br. J. Nutr. 2008, 99 (4), 715-722. (Pubitemid 351351624)
13. Lee, W. J.; Ou, H. C.; Hsu, W. C.; Chou, M. M.; Tseng, J. J.; Hsu, S. L.; Tsai, K. L.; Sheu, W. H. Ellagic acid inhibits oxidized LDLmediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J. Vasc. Surg. 2010, 52 (5), 1290-1300.
14. Ou, H. C.; Lee, W. J.; Lee, S. D.; Huang, C. Y.; Chiu, T. H.; Tsai, K. L.; Hsu, W. C.; Sheu, W. H. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol. Appl. Pharmacol. 2010, 248 (2), 134-143.
15. Losso, J. N.; Bansode, R. R.; Trappey, A., 2nd; Bawadi, H. A.; Truax, R. In vitro anti-proliferative activities of ellagic acid. J. Nutr. Biochem. 2004, 15 (11), 672-678. (Pubitemid 39611365)
16. Huang, S. T.; Wang, C. Y.; Yang, R. C.; Wu, H. T.; Yang, S. H.; Cheng, Y. C.; Pang, J. H. S. Ellagic acid, the active compound of phyllanthus urinaria, exerts in vivo anti-angiogenic effect and inhibits MMP-2 activity. eCAM 2011, DOI: 10.1093/ecam/nep207.
17. Khateeb, J.;Gantman,A.;Kreitenberg,A. J.;Aviram,M.; Fuhrman, B. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-γ pathway. Atherosclerosis 2010, 208 (1), 119-125.
18. Kuo, W. W.; Huang, C. Y.; Chung, J. G.; Yang, S. F.; Tsai, K. L.; Chiu, T. H.; Lee, S. D.; Ou, H. C. Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoproteininduced injury by direct antioxidant action. J. Vasc. Surg. 2009, 50 (4), 849-860.
19. Wu, W. S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006, 25 (4), 695-705.
20. Kang, J. H.; Kim, J. K.; Park, W. H.; Park, K. K.; Lee, T. S.; Magae, J.; Nakajima, H.; Kim, C. H.; Chang, Y. C. Ascochlorin suppresses oxLDL-induced MMP-9 expression by inhibiting the MEK/ERK signaling pathway in human THP-1 macrophages. J. Cell Biochem. 2007, 102 (2), 506-514. (Pubitemid 47519423)
21. Wang, H. H.; Hsieh, H. L.; Wu, C. Y.; Sun, C. C.; Yang, C. M. Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes. Glia 2009, 57 (1), 24-38.
22. Apostolov, E. O.; Basnakian, A. G.; Yin, X.; Ok, E.; Shah, S. V. Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway. Am. J. Physiol. Heart Circ. Physiol. 2007, 292 (4), H1836-H1846. (Pubitemid 46578055)
23. Lin, C. W.; Shen, S. C.; Chien, C. C.; Yang, L. Y.; Shia, L. T.; Chen, Y. C. 12-O-Tetradecanoylphorbol-13-acetate-induced invasion/ migration of glioblastoma cells through activating PKCR/ERK/NF-κBdependent MMP-9 expression. J. Cell Physiol. 2010, 225 (2), 472-481.
24. Tung, W. H.; Tsai, H. W.; Lee, I. T.; Hsieh, H. L.; Chen, W. J.; Chen, Y. L.; Yang, C. M. Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-κB signalling dependent on MAPKs and reactive oxygen species. Br. J. Pharmacol. 2010, 161 (7), 1566-1583.
25. Burgermeister, E.; Chuderland, D.; Hanoch, T.; Meyer, M.; Liscovitch, M.; Seger, R. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor γ. Mol. Cell. Biol. 2007, 27 (3), 803-817. (Pubitemid 46174547)
26. Reuben, P. M.; Brogley, M. A.; Sun, Y.; Cheung, H. S. Molecular mechanism of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase Cα. J. Biol. Chem. 2002, 277 (17), 15190-15198. (Pubitemid 34952598)
27. Adya, R.; Tan, B. K.; Punn, A.; Chen, J.; Randeva, H. S. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc. Res. 2008, 78 (2), 356-365. (Pubitemid 351556097)
28. Jin, Y. J.; Park, I.; Hong, I. K.; Byun, H. J.; Choi, J.; Kim, Y. M.; Lee, H. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α5β1/αvβ3- dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell. Signal. 2011, 23 (1), 125-134.
29. Rajavashisth, T. B.; Liao, J. K.; Galis, Z. S.; Tripathi, S.; Laufs, U.; Tripathi, J.; Chai, N. N.; Xu, X. P.; Jovinge, S.; Shah, P. K.; Libby, P. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J. Biol. Chem. 1999, 274 (17), 11924-11929.
30. Li, D.; Liu, L.; Chen, H.; Sawamura, T.; Ranganathan, S.; Mehta, J. L. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 2003, 107 (4), 612-617. (Pubitemid 36176813)
31. Li, L.; Renier, G. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells. Atherosclerosis 2009, 204 (1), 40-46.
32. Devipriya, N.; Sudheer, A. R.; Srinivasan, M.; Menon, V. P. Effect of ellagic acid, a plant polyphenol, on fibrotic markers (MMPs and TIMPs) during alcohol-induced hepatotoxicity. Toxicol. Mech. Methods 2007, 17 (6), 349-356. (Pubitemid 47124023)
33. Hua, Y.; Xue, J.; Sun, F.; Zhu, L.; Xie, M. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARR/γ and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes. Pharmacology 2009, 83 (1), 18-25.
34. Chung, S. W.; Kang, B. Y.; Kim, S. H.; Pak, Y. K.; Cho, D.; Trinchieri, G.; Kim, T. S. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB. J. Biol. Chem. 2000, 275 (42), 32681-32687.
35. Mertens-Talcott, S. U.; Talcott, S. T.; Percival, S. S. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J. Nutr. 2003, 133 (8), 2669-2674. (Pubitemid 36935989)
36. Karlsson, S.; Nanberg, E.; Fjaeraa, C.; Wijkander, J. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br. J. Nutr. 2010, 103 (8), 1102-1109.